Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: A gynecologic oncology group study

Gynecologic Oncology - Tập 23 - Trang 358-363 - 1986
J.Tate Thigpen1, John A. Blessing2, Howard D. Homesley3, George C. Lewis4
1Department of Medicine and Obstetrics and Gynecology, University of Mississippi School of Medicine, Jackson, Mississippi, USA
2Roswell Park, Memorial Institute, Buffalo, New York, USA
3Department of Obstetrics and Gynecology, Section on Gynecologic Oncology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina, USA
4Department of Obstetrics and Gynecology, Jefferson Medical College, Chairman, Gynecologic Oncology Group, Philadelphia, Pennsylvania 19107 USA

Tài liệu tham khảo

Benjamin, R., Keating, M., Valdivieso, M., et al. Phase I–II study of piperazinedione in adults with solid tumors and acute leukemia, Cancer Treat. Rep., 63, 939–943.

Rosenburg, 1969, Platinum compounds: A new class of potent antitumor agents, Nature (London), 22, 385, 10.1038/222385a0

Slavik, 1982, Phase II studies in advanced, recurrent pelvic malignancies conducted by the Gynecologic Oncology Group (GOG): Experimental design and experience, Amer. J. Clin. Oncol., 5, 483, 10.1097/00000421-198210000-00003

Yordan, 1984, Chemotherapy of vulvar and vaginal neoplasms, 85

Dvorak, 1971, Cytembena treatment of advanced gynecologic carcinomas, Neoplasma, 18, 461

Thigpen, 1981, Cis-platinum in treatment of advanced or recurrent squamous cell carinoma of the cervix: A phase II study of the Gynecologic Oncology Group, Cancer, 48, 899, 10.1002/1097-0142(19810815)48:4<899::AID-CNCR2820480406>3.0.CO;2-6

Thông tin
Thông tin xuất bản

Gynecologic Oncology

Tập 23

358-363

Thông tin tác giả